Answers are grounded in this paper and cite their sources.
OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).
No takes yet. Share an insight, caveat, or question.
Ashmawy et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: